# IVUS Guided PCI for CKD to Reduce CI-AKI

> **NCT05913362** · NA · UNKNOWN · sponsor: **Jilin University** · enrollment: 320 (estimated)

## Conditions studied

- Coronary Artery Disease
- Chronic Kidney Diseases

## Interventions

- **BEHAVIORAL:** IVUS based ultralow contrast PCI

## Key facts

- **NCT ID:** NCT05913362
- **Lead sponsor:** Jilin University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05913362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05913362, "IVUS Guided PCI for CKD to Reduce CI-AKI". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05913362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*